1. Home
  2. OPXS vs PLRX Comparison

OPXS vs PLRX Comparison

Compare OPXS & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Optex Systems Holdings Inc.

OPXS

Optex Systems Holdings Inc.

HOLD

Current Price

$10.69

Market Cap

94.1M

Sector

Technology

ML Signal

HOLD

Logo Pliant Therapeutics Inc.

PLRX

Pliant Therapeutics Inc.

HOLD

Current Price

$1.24

Market Cap

81.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OPXS
PLRX
Founded
1987
2015
Country
United States
United States
Employees
72
N/A
Industry
Electronic Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
94.1M
81.1M
IPO Year
2009
2020

Fundamental Metrics

Financial Performance
Metric
OPXS
PLRX
Price
$10.69
$1.24
Analyst Decision
Strong Buy
Hold
Analyst Count
1
4
Target Price
$16.10
$2.67
AVG Volume (30 Days)
31.7K
580.8K
Earning Date
05-12-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
34.55
29.97
EPS
0.03
N/A
Revenue
$24,530,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$350.00
N/A
Revenue Growth
17.63
N/A
52 Week Low
$6.10
$1.09
52 Week High
$17.76
$1.95

Technical Indicators

Market Signals
Indicator
OPXS
PLRX
Relative Strength Index (RSI) 31.62 42.22
Support Level $9.96 $1.12
Resistance Level $13.89 $1.37
Average True Range (ATR) 0.67 0.07
MACD -0.14 -0.01
Stochastic Oscillator 12.01 34.09

Price Performance

Historical Comparison
OPXS
PLRX

About OPXS Optex Systems Holdings Inc.

Optex Systems Holdings Inc manufactures optical sighting systems and assemblies for the U.S. Department of Defense, foreign military applications, and commercial markets. Its products are installed on a variety of United States military land vehicles, such as the Abrams and Bradley fighting vehicles, light armored and security vehicles, and have been selected for installation on the Stryker family of vehicles. The company's operating segment includes Optex Systems Richardson, Applied Optics Center Dallas, and others. It generates maximum revenue from the Optex Systems Richardson segment. Some of its products include M17 Day/Thermal Periscope; DDAN / M36 Sights; Laser Protected Periscopes; Muzzle Reference Sensor, and others.

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.

Share on Social Networks: